Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: APPILI THERAPEUTICS USA INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2025-09-30 to 2030-06-01
Current total value of award: $3605418
Description: TO ADVANCE THE DEVELOPMENT OF THE VACCINE CANDIDATE THROUGH EARLY CLINICAL DEVELOPMENT, INCLUDING THE NECESSARY PREPARATORY ACTIVITIES AND EXECUTION OF STUDIES.